Cryo Cell International (CCEL) Cash from Operations (2010 - 2026)

Cryo Cell International (CCEL) has reported Cash from Operations for 17 consecutive years, with 1845911.0 the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Operations rose 161.09% year-over-year to 1845911.0; the TTM figure through May 2026 stood at 6315267.0 (up 0.96% YoY), while the FY2025 annual figure was 5478606.0, down 8.86% from the prior year.
• Cash from Operations grew to 1845911.0 in Q2 2026 per CCEL's latest filing, from 651827.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 3344314.0 in Q4 2023 and bottomed at 356865.0 in Q1 2024.
• Historically, Cash from Operations has averaged 1748869.72 across 5 years, with a median of 1894162.5 in 2023.
• Annual changes were most pronounced in 2024 — Cash from Operations tumbled 121.71% — and 2025, when it surged 367.35%.
• Cryo Cell International's Cash from Operations stood at 2429736.0 in 2022, then surged by 37.64% to 3344314.0 in 2023, then sank by 35.5% to 2156993.0 in 2024, then tumbled by 40.62% to 1280813.0 in 2025, then surged by 44.12% to 1845911.0 in 2026.
• Business Quant data shows CCEL's Cash from Operations at 1845911.0 in Q2 2026, 651827.0 in Q1 2026, and 1280813.0 in Q4 2025.